NEW YORK — He is famous for his founding roles at Facebook and Napster, but these days the billionaire philanthropist Sean Parker is turning his attention to fighting cancer. Three years ago, he announced a $250 million investment to build teams of scientists for immunotherapy research, one of the hottest fields in taking on cancer.

In an interview with STAT last week in his hotel suite overlooking Central Park, Parker spoke intensely about his belief that the government needs to move far more aggressively in investing in biotech, life sciences, and health care. He returned repeatedly to the subject of job creation in those fields. And he said it was urgent that China not eclipse the United States in scientific innovation. This interview was edited and condensed for clarity.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • Please, be not so casual about “eliminating diseases prior to birth through gene editing”. Looks like you need a bit more interaction with scientists to understand what this means and what the risks are. They won’t be easily solved. And remember, Nobels are given for thinking as well as working in a lab- a postdoc may be able to do the work in a week, but few of us could have done the thinking.

  • I am very disappointed at the number of interesting articles whereby in order to see the ‘entire’ article’ there is a fee. It’s a ‘teaser’ and even if I were inclined to ‘pay’, there’s just too many of these ‘instances’. ALSO, I do not like having my credit card information ‘out there’. Guess I’ll just have to delete the ‘source’…or block it.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy